SCHEMBL28804341

SCHEMBL28804341

O=C(O)C1=Cc2cc(C(=O)O)ccc2OC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 1/20 0.50
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
HTT P42858 1/20 0.46
ALOX5 P09917 2/20 0.44
MAPT P10636 6/20 0.43
KDM4E B2RXH2 3/20 0.43
RARA P10276 2/20 0.43
RARG P13631 2/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RARB P10826 1/20 0.42
SRD5A2 P31213 1/20 0.41
MAOB P27338 4/20 0.40
SHMT2 P34897 1/20 0.40
MAOA P21397 3/20 0.40
NPC1 O15118 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL415706 0.85 CA12 (0.59) ALDH1A1MEN1KMT2AHTTALOX5
SCHEMBL545919 0.83 MEN1 (0.46) ALDH1A1MEN1KMT2AHTTALOX5
SCHEMBL3187719 0.83 MEN1 (0.46) ALDH1A1MEN1KMT2AHTTALOX5
SCHEMBL432482 0.82 MEN1 (0.66) ALDH1A1MEN1KMT2AHTTALOX5
SCHEMBL416748 0.82 MAPT (0.56) ALDH1A1MEN1KMT2AHTTALOX5
SCHEMBL20839505 0.82 MEN1 (0.48) ALDH1A1MEN1KMT2AHTTALOX5
SCHEMBL212724 0.81 ALOX5 (0.64) ALDH1A1MEN1KMT2AALOX5MAPT
SCHEMBL16397645 0.81 ALOX5 (0.64) ALDH1A1MEN1KMT2AALOX5MAPT
SCHEMBL31538745 0.80 ALOX5 (0.57) ALDH1A1MEN1KMT2AHTTALOX5
Hydrochloric Acid SCHEMBL23532714 0.79 ALOX5 (0.62) ALDH1A1MEN1KMT2AALOX5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103200936-B Novel N-hydroxybenzamide compounds for the treatment of cancer HOFFMANN LA ROCHE 2015-03-11 CN disclosed
CN-103200936-A Novel N-hydroxybenzamide compounds for the treatment of cancer HOFFMANN LA ROCHE 2013-07-10 CN disclosed